Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur J Health Econ. 2010 Oct;11(5):449-55. doi: 10.1007/s10198-009-0181-2. Epub 2009 Sep 23.

Expenditures of the German statutory health insurance system for patients suffering from acute coronary syndrome and treated with percutaneous coronary intervention.

Author information

1
Institut für Prävention und Gesundheitsförderung an der Universität Duisburg-Essen, Max-Fiedler Strasse 6, 45128 Essen, Germany. friedel@ipg-uni-essen.de

Abstract

Patients with acute coronary syndrome (ACS) are in need of cost-intensive treatment involving different aspects of the German Health System. Percutaneous coronary intervention (PCI) is the treatment of choice for a large proportion of cases. In the present study, an analysis of the cost impact of ACS with focus on PCI therapy was conducted across-the-board for the German Health System. Results indicated that 85% of all costs arising from treatment of ACS with a trial of PCI are due to in-patient care. Projection of results onto the entire insurant collective of the statutory health system estimated a total of Euro 954,995,603-a proportional 0.7% of all expenditure by statutory health insurance in 2005.

PMID:
19774404
DOI:
10.1007/s10198-009-0181-2
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center